Tenecteplase for Intravenous Stroke Thrombolysis in Recent DOAC Users

NCT07092709 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

912

Enrollment

OTHER

Sponsor class

Conditions

Acute Ischemic Stroke

Interventions

DRUG: Tenecteplase (TNK) (0.25 mg/kg, to maximum of 25mg)
DRUG: Placebo

Sponsor

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University